Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 4:47 pm Sale | 2024-09-30 | 13G | IMMUNOCORE HLDGS PLC ADS IMCR | Rock Springs Capital Management LP | 0 0.000% | -2,661,507 (Position Closed) | Filing History |
| 2024-11-08 10:52 am Purchase | 2024-09-30 | 13G | IMMUNOCORE HLDGS PLC ADS IMCR | Wellington Management Group LLP | 7,299,746 14.770% | 2,987,135 (+69.27%) | Filing History |
| 2024-09-10 1:49 pm Purchase | 2024-08-31 | 13G | IMMUNOCORE HLDGS PLC ADS IMCR | T. Rowe Price Investment Management, Inc. | 5,164,899 10.300% | 5,164,899 (New Position) | Filing History |
| 2024-03-11 08:19 am Purchase | 2024-03-08 | 13G | IMMUNOCORE HLDGS PLC ADS IMCR | FMR LLC | 4,386,070 10.017% | 4,386,070 (New Position) | Filing |
| 2024-03-07 9:45 pm Sale | 2024-03-07 | 13D | IMMUNOCORE HLDGS PLC ADS IMCR | GENERAL ATLANTIC, L.P. | 1,747,849 3.500% | -858,835 (-32.95%) | Filing History |
| 2024-02-14 2:09 pm Sale | 2023-12-31 | 13G | IMMUNOCORE HLDGS PLC ADS IMCR | Rock Springs Capital Management LP | 2,661,507 5.380% | -659,559 (-19.86%) | Filing History |
| 2024-02-14 10:03 am Purchase | 2023-12-31 | 13G | IMMUNOCORE HLDGS PLC ADS IMCR | T. Rowe Price Associates, Inc. | 2,944,574 6.000% | 2,944,574 (New Position) | Filing History |
| 2024-02-14 07:57 am Purchase | 2023-12-31 | 13G | IMMUNOCORE HLDGS PLC ADS IMCR | RTW Investments, LP | 6,096,387 12.300% | 537,065 (+9.66%) | Filing History |
| 2024-02-08 10:03 am Sale | 2023-12-29 | 13G | IMMUNOCORE HLDGS PLC ADS IMCR | Wellington Management Group LLP | 4,312,611 8.720% | -1,186,066 (-21.57%) | Filing History |
| 2024-02-06 11:00 am Purchase | 2024-01-31 | 13G | IMMUNOCORE HLDGS PLC ADS IMCR | Wellington Management Group LLP | 5,498,677 11.120% | 5,498,677 (New Position) | Filing History |
| 2024-02-01 5:25 pm Sale | 2024-01-30 | 13D | IMMUNOCORE HLDGS PLC ADS IMCR | Baker Bros. Advisors LP | 2,452,871 4.990% | -2,232,819 (-47.65%) | Filing History |
| 2023-09-18 2:40 pm Sale | 2023-09-15 | 13D | IMMUNOCORE HLDGS PLC ADS IMCR | GENERAL ATLANTIC, L.P. | 2,606,684 5.300% | -249,213 (-8.73%) | Filing History |
| 2023-06-15 5:17 pm Sale | 2023-06-13 | 13D | IMMUNOCORE HLDGS PLC ADS IMCR | GENERAL ATLANTIC, L.P. | 2,855,897 5.900% | -369,803 (-11.46%) | Filing History |
| 2023-02-14 2:53 pm Purchase | 2022-12-31 | 13G | IMMUNOCORE HLDGS PLC ADS IMCR | Rock Springs Capital Management LP | 3,321,066 7.330% | 849,511 (+34.37%) | Filing History |
| 2023-02-14 10:05 am Purchase | 2022-10-31 | 13G | IMMUNOCORE HLDGS PLC ADS IMCR | RTW Investments, LP | 5,559,322 12.300% | 5,559,322 (New Position) | Filing History |
| 2023-01-17 5:25 pm Sale | 2022-01-12 | 13D | IMMUNOCORE HLDGS PLC ADS IMCR | GENERAL ATLANTIC, L.P. | 3,225,700 7.100% | -614,969 (-16.01%) | Filing History |
| 2023-01-03 6:56 pm Sale | 2022-12-29 | 13D | IMMUNOCORE HLDGS PLC ADS IMCR | GENERAL ATLANTIC, L.P. | 3,840,669 8.480% | -516,223 (-11.85%) | Filing History |
| 2022-12-20 5:13 pm Sale | 2022-12-16 | 13D | IMMUNOCORE HLDGS PLC ADS IMCR | GENERAL ATLANTIC, L.P. | 4,356,892 9.620% | -965,683 (-18.14%) | Filing History |
| 2022-09-07 11:37 am Sale | 2022-08-31 | 13G | IMMUNOCORE HLDGS PLC ADS IMCR | Malin Life Sciences Holdings Limited | 2,109,425 4.560% | -280,554 (-11.74%) | Filing History |
| 2022-07-21 5:13 pm Purchase | 2022-07-20 | 13D | IMMUNOCORE HLDGS PLC ADS IMCR | GENERAL ATLANTIC, L.P. | 5,322,575 11.500% | 5,322,575 (New Position) | Filing History |